We are live on ! Find out more
NVOS

Novo Integrated Sciences, Inc. Common Stock
NVOS

Delisted

NVOS was delisted on the 5th of November, 2024.

Back to rankings

7 hedge funds and large institutions have $965K invested in Novo Integrated Sciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more capital invested

Capital invested by funds: $570K → $965K (+$395K)

0.03% more ownership

Funds ownership: 1.43% → 1.46% (+0.03%)

13% less funds holding

Funds holding: 8 → 7 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$37.4K
2
BlackRock
BlackRock
New York
+$21K
3
TRCT
Tower Research Capital (TRC)
New York
+$1.56K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.36K
5
Wells Fargo
Wells Fargo
California
+$17

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$19K
2
TSS
Two Sigma Securities
New York
-$18K

NVOS Hedge Fund Activity: Q1 2022 in Review

7 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q1 2022, worth a combined $965K — up 69% from $570K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NVOS and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 4 added.

The largest buyer was CVI Holdings, opening a new position worth an estimated $37.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $19K sold.

  • 7 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q1 2022, down from 8 in Q4 2021.
  • Funds reported $965K of Novo Integrated Sciences, Inc. Common Stock stock for Q1 2022, up 69% quarter-over-quarter.
  • 1 fund opened new Novo Integrated Sciences, Inc. Common Stock positions in Q1 2022 and 2 closed out, a net change of -1 holder.
  • The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q1 2022 was CVI Holdings, an estimated $37.4K added.
  • The largest Novo Integrated Sciences, Inc. Common Stock seller in Q1 2022 was Renaissance Technologies, an estimated $19K sold.

Based on aggregated 13F filings for Q1 2022.